211 related articles for article (PubMed ID: 36518089)
1. Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines.
Murayama A; Kamamoto S; Murata N; Yamasaki R; Yamada K; Yamashita E; Saito H; Tanimoto T; Ozaki A
J Gastroenterol Hepatol; 2023 Apr; 38(4):565-573. PubMed ID: 36518089
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline.
Murayama A; Yamada K; Yoshida M; Kaneda Y; Saito H; Sawano T; Shrestha S; Shrestha R; Tanimoto T; Ozaki A
Clin J Am Soc Nephrol; 2022 Jun; 17(6):819-826. PubMed ID: 35623883
[TBL] [Abstract][Full Text] [Related]
4. Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.
Yamamoto K; Murayama A; Ozaki A; Saito H; Sawano T; Tanimoto T
Int Urogynecol J; 2021 Feb; 32(2):443-451. PubMed ID: 33151353
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
Checketts JX; Sims MT; Vassar M
JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
[TBL] [Abstract][Full Text] [Related]
6. Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan.
Murayama A; Aizawa M; Byreddy KR; Higuchi K; Senoo Y
J Am Heart Assoc; 2024 Apr; 13(8):e034506. PubMed ID: 38606773
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan and the United States.
Mamada H; Murayama A; Kamamoto S; Kaneda Y; Yoshida M; Sugiura S; Yamashita E; Kusumi E; Saito H; Sawano T; Tanimoto T; Vassar M; Ozieranski P; Ozaki A
Arthritis Care Res (Hoboken); 2023 Jun; 75(6):1278-1286. PubMed ID: 36194077
[TBL] [Abstract][Full Text] [Related]
8. Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis.
Murayama A; Kida F; Ozaki A; Saito H; Sawano T; Tanimoto T
Otolaryngol Head Neck Surg; 2022 May; 166(5):869-876. PubMed ID: 34399654
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan.
Murayama A; Kugo H; Senoo Y
BMJ Open; 2024 Jun; 14(6):e086396. PubMed ID: 38908845
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
[TBL] [Abstract][Full Text] [Related]
11. Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.
Holloway RG; Mooney CJ; Getchius TS; Edlund WS; Miyasaki JO
Neurology; 2008 Jul; 71(1):57-63. PubMed ID: 18591506
[TBL] [Abstract][Full Text] [Related]
12. Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines.
Carlisle A; Bowers A; Wayant C; Meyer C; Vassar M
Eur Urol; 2018 Sep; 74(3):348-354. PubMed ID: 29747945
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension.
Senoo Y; Saito H; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
Medicine (Baltimore); 2021 Mar; 100(12):e24816. PubMed ID: 33761642
[TBL] [Abstract][Full Text] [Related]
14. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019.
Murayama A; Kamamoto S; Kawashima M; Saito H; Yamashita E; Tanimoto T; Ozaki A
BMJ Open; 2023 Apr; 13(4):e068237. PubMed ID: 37072354
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.
Horn J; Checketts JX; Jawhar O; Vassar M
JAMA Otolaryngol Head Neck Surg; 2018 Mar; 144(3):194-201. PubMed ID: 29270633
[TBL] [Abstract][Full Text] [Related]
17. Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
Grindal AW; Khan R; Scaffidi MA; Rumman A; Grover SC
Inflamm Bowel Dis; 2019 Mar; 25(4):642-645. PubMed ID: 30295831
[TBL] [Abstract][Full Text] [Related]
18. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
[No Abstract] [Full Text] [Related]
19. Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan.
Sawano T; Ozaki A; Saito H; Shimada Y; Tanimoto T
JAMA Netw Open; 2019 May; 2(5):e193817. PubMed ID: 31099864
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Financial Conflicts of Interest and Quality of Evidence Underlying the American Diabetes Association Clinical Practice Guidelines: The Standards of Medical Care in Diabetes, 2021.
Shigeta H; Murayama A; Kamamoto S; Saito H; Ozaki A
Cureus; 2023 Mar; 15(3):e36567. PubMed ID: 37095789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
